metricas
covid
Medicina Clínica (English Edition) Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers ...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis
Beneficios de los inhibidores de SGLT2 combinados con bloqueadores del sistema renina-angiotensina en los resultados cardiovasculares de los pacientes con enfermedad renal crónica: una revisión sistémica y un metaanálisis
Ting Liua,1, Rui Lib,1, Xiaoxia Wangb,1, Xingxing Gaob, Xiaodong Zhanga,
Corresponding author
zxdspl@163.com

Corresponding author.
a Department of Nephrology, The First Hospital of Shanxi Medical University, Taiyuan, China
b Shanxi Medical University, Taiyuan, China
Read
12
Times
was read the article
5
Total PDF
7
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2023 3 5 3 8
2023 1 2 2 4

Follow this link to access the full text of the article